Skip to main content

Day: January 29, 2026

Condor Provides a Drilling Update for Uzbekistan and Announces the Sale of Its Turkish Assets

CALGARY, Alberta, Jan. 29, 2026 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based, internationally focused energy transition company with active operations in Central Asia is pleased to provide an update on its Uzbekistan and Türkiye projects. UZBEKISTAN DRILLING UPDATE The Company’s second well of its multi-well campaign, Andakli-21 (“A-21”), has reached TD at 3456 meters which includes 1279 meters of open hole lateral section, setting a record for the longest horizontal drilled in Uzbekistan. The A-21 well was successfully geo-steered to intersect over 960 meters of carbonate reservoir as defined by drill cuttings and containing greater than 6% visible porosity. Reservoir quality exceeded pre-drill expectations with 223 meters of the lateral section containing up to 12% visible porosity...

Continue reading

YETI Holdings, Inc. Announces Reporting Date for Fourth Quarter and Fiscal 2025 Financial Results

AUSTIN, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) — YETI Holdings, Inc. (“YETI”) (NYSE: YETI) today announced that it plans to report its fourth quarter and fiscal year 2025 financial results on Thursday, February 19, 2026, before the market opens. YETI will host a conference call at 8:00 a.m. ET to discuss its financial results. Investors and analysts who wish to participate in the call are invited to dial 800-717-1738 (international callers, please dial 646-307-1865) approximately 10 minutes prior to the start of the call. A live webcast of the conference call will also be available in the investor relations section of YETI’s website, www.investors.yeti.com. A recorded replay of the call will be available shortly after the conclusion of the call and remain available until March 5, 2026. To access the telephone replay, dial 844-512-2921...

Continue reading

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

Expands clinical expertise to support disciplined advancement of the PSX-001 program MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Advisory Board (“CAB”): Murray B. Stein, MD, MPH; Andrew Cutler, MD; and Amir Kalali, MD. The CAB was formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The addition of Drs. Stein, Cutler, and Kalali further strengthens the Board’s expertise across psychiatry, neurobiology, psychopharmacology, and clinical development, reinforcing the scientific rigor...

Continue reading

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, announces the presentation of positive US-study clinical trial results at Leipzig Interventional Course in Leipgzig, Germany on Wednesday, January 28, 2026.  The study, conducted at the University of California San Francisco, San Francisco VA Medical Center, and San Francisco General Hospital, showed Lumee oxygen tissue monitoring is a safe and effective method for long term monitoring of peripheral artery disease (PAD) patients. The data also demonstrated strong correlation...

Continue reading

Memorial Hospital Selects CareCloud’s HealthLine to Drive Supply Chain Efficiency and Inventory Integrity

SOMERSET, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced the signing of Memorial Hospital in Marysville, Ohio for its HealthLine supply chain management platform. The agreement brings CareCloud’s comprehensive clinical supply chain solution to a community healthcare system committed to operational excellence and resource stewardship. The HealthLine platform entered the CareCloud product portfolio through its acquisition of Medsphere in August 2025, adding a nationally recognized supply chain management system to complement CareCloud’s AI-driven ambulatory, RCM, and analytics offerings. As healthcare organizations face mounting pressure to reduce waste, improve charge capture,...

Continue reading

BLAQclouds, Inc. Announces Live Launch of ApolloCASH on February 1, 2026

ROBESONIA, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) — BLAQclouds, Inc. (OTC: BCDS), a company focused on Web3 infrastructure, fintech, and Web3 payments, today announced the official live launch of ApolloCASH, its next-generation global settlement and remittance platform, scheduled to go live on February 1, 2026 at 5:00 PM Mountain Time. BLAQclouds encourages users to pre-register at http://www.ApolloCASH.io ahead of the live launch. Pre-registration is capped at 500 participants, and availability is nearly full. ApolloCASH is designed to modernize how value moves globally, bringing speed, transparency, and real-time execution to everyday sends and redeems. Built within the BLAQclouds ecosystem, ApolloCASH blends familiar consumer payment rails with blockchain-based settlement, delivering a seamless and programmable financial experience.NEW...

Continue reading

Immutep Quarterly Activities Report Q2 FY26

Media ReleaseEntered into strategic collaboration with Dr. Reddy’s for commercialisation of eftilagimod alfa (efti) in all countries outside North America, Europe, Japan, and Greater China In January 2026, Immutep received ~A$30 million upfront payment from Dr. Reddy’s and is eligible to receive up to ~A$528 million in potential milestones, plus royalties on commercial sales of efti Strong operational progress reported for TACTI-004 (KEYNOTE-F91) Phase III trial evaluating efti in first line non-small cell lung cancer (1L NSCLC), with completion of the futility analysis on track for the first quarter of CY2026 Data from INSIGHT-003 at ESMO Congress 2025 show combination of efti with KEYTRUDA® and chemotherapy generates strong response rates across all PD-L1 expression levels in 1L NSCLC, including 61.7% ORR in low & no PD-L1 (TPS

Continue reading

First Mid Bancshares, Inc. Announces Fourth Quarter 2025 Results

MATTOON, Ill., Jan. 29, 2026 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (the “Company”) today announced its financial results for the quarter ended December 31, 2025. HighlightsRecord high quarterly net income of $23.7 million, or $0.99 diluted EPS Adjusted quarterly net income* of $25.3 million, or $1.06 diluted EPS Total loans of $6.01 billion, quarterly increase of $187.3 million, or 3.2% and an increase of 6.0% for the year Total deposits of $6.40 billion, quarterly increase of $105.7 million, or 1.7% and an increase of 5.6% for the year Tangible book value per share* increased 4.3% during the quarter to $29.42 and an increase of 20.3% for the year Received regulatory approval for the acquisition of Two Rivers Financial Group, Inc. Board of Directors declares regular quarterly dividend of $0.25 per share“We...

Continue reading

Linkhome Launches AI-Powered Mortgage Services on Its Platform

Irvine, California, Jan. 29, 2026 (GLOBE NEWSWIRE) — Linkhome Holdings Inc. (Nasdaq: LHAI) today announced the official launch of AI-powered mortgage services on its real estate platform. The new service allows users to access mortgage-related services directly through the Linkhome platform, further enhancing the Company’s end-to-end, technology-driven homebuying experience. The AI-powered mortgage services are provided through Linkhome Mortgage Inc., a wholly owned subsidiary acquired by Linkhome Holdings Inc. Linkhome Mortgage Inc. is a licensed U.S. mortgage company registered with the Nationwide Multistate Licensing System (NMLS). The company has initially been authorized to conduct mortgage-related business in the State of California and operates in full compliance with applicable state and federal regulatory requirements. With...

Continue reading

EagleNXT Drones Supporting Wildlife and Agriculture Monitoring Operations

Idaho Department of Fish and Game (IDFG) Enhancing Capabilities with Advanced eBee Drone ALLEN, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of full stack drone, sensors and software solutions for customers worldwide in the commercial and government verticals, today announces the Idaho Department of Fish and Game (IDFG) is acquiring an eBee X drone. This acquisition supports IDFG’s efforts to monitor and reduce crop depredation on private agricultural lands caused by big game species such as elk, deer, and moose. The move directly supports IDFG’s statutory mission to preserve, protect, and manage Idaho’s wildlife resources, including addressing human-wildlife interaction where big game animals cause economic losses...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.